Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Suzana, Kukulj"'
Autor:
Suzana Kukulj, Gordana Drpa, Jelena Knezevic, Miroslav Samarzija, Maja Šutić, Jurica Baranašić, Marko Jakopović
Publikováno v:
Radiology and Oncology, Vol 54, Iss 4, Pp 437-446 (2020)
Radiology and Oncology
Radiology and oncology
Radiology and Oncology
Radiology and oncology
Background The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) were analyzed in various carcinomas and their potential prognostic significance was determined. The objective of present s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c33b1fa14af8fad888fc52648427435d
https://doi.org/10.2478/raon-2020-0054
https://doi.org/10.2478/raon-2020-0054
Publikováno v:
Psychiatria Danubina. 32(Suppl 4)
Stigma in lung cancer has been associated with diagnostic and treatment delay and with poor outcomes. Personality has impact on the perception of someone's life situation and interacts with psychosocial variables and coping strategies. The vulnerabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fce6e9ed011e118fdcf18f95e363f58
https://pubmed.ncbi.nlm.nih.gov/33212459
https://pubmed.ncbi.nlm.nih.gov/33212459
Autor:
Lela Bitar, Sven Seiwerth, Dinko Stancic Rokotov, Fran Seiwerth, Luka Brcic, Suzana Kukulj, Zoran Janevski, Gzim Redžepi, Feđa Džubur, Tomislav Dujmović, Goran Glodić, Miroslav Samaržija, Anton Mažuranić, Željko Djaković, Mateja Jankovic Makek, Antun Koprivanac, Ante Marušić, Sanja Pleština, Marko Jakopović
Publikováno v:
Liječnički vjesnik. 142
Malignant pleural mesothelioma (MPM) is an aggressive tumor that develops from the mesothelial cells lining the pleural cavity. The most relevant risk factor is asbestos exposure. Despite therapy the median survival is poor ranging from four to 18 mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f783f89b84fbba438bd5805e273d8e2
https://doi.org/10.26800/lv-142-9-10-47
https://doi.org/10.26800/lv-142-9-10-47
Autor:
Blazenka Barisic, Marija Barišić Kutija, Suzana Kukulj, Miroslav Samarzija, Katherina Bernadette Sreter
Publikováno v:
Molecular and Clinical Oncology. 6:921-924
Adie's syndrome (AS) and paraneoplastic sensorimotor neuropathy with cerebellar ataxia (PSN CA) are extremely rare, rapidly progressive, autoimmune diseases associated with the development of antibodies against neuronal- specific Hu proteins that are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec523bec5ef800afd6ed44c7e0db25f
https://doi.org/10.3892/mco.2017.1248
https://doi.org/10.3892/mco.2017.1248
Publikováno v:
Liječnički vjesnik
Volume 142
Issue 9-10
Volume 142
Issue 9-10
Uvod: Rak pluća je povezan s visokom učestalošću depresije i stigme. I depresija i stigma povezane su s lošijim ishodima u dijagnostici i liječenju raka pluća te je potrebno njihovo daljnje istraživanje i uključivanje u terapiju. Cilj: Istra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::053da6b7ff960a5893e391ee54e37b13
https://doi.org/10.26800/lv-142-9-10-46
https://doi.org/10.26800/lv-142-9-10-46
Autor:
Goran Glodić, Antun Koprivanac, Anton Mažuranić, Tomislav Dujmović, Ante Marušić, Sanja Pleština, Suzana Kukulj, Lela Bitar, Fran Seiwerth, Sven Seiwerth, Luka Brčić, Dinko Stančić Rokotov, Zoran Janevski, Željko Djaković, Feđa Džubur, Mateja Janković Makek, Gzim Redžepi, Miroslav Samaržija, Marko Jakopović
Publikováno v:
Liječnički vjesnik
Volume 142
Issue 9-10
Volume 142
Issue 9-10
Maligni pleuralni mezoteliom rijetka je i agresivna primarna novotvorina mezotelnih stanica pleure. Glavni rizični čimbenik je izloženost azbestu, najčešće uz latenciju od 30–50 godina. Unatoč terapiji medijan preživljenja je od 4 do 18 mje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c904e9da2b1cda8feb2a0c3de1be5d91
https://doi.org/10.26800/lv-142-9-10-47
https://doi.org/10.26800/lv-142-9-10-47
Publikováno v:
Precision Radiation Oncology. 2:61-63
The common treatment modality for extensive‐ stage small cell lung cancer is chemotherapy, which significantly improves survival in these patients. However, the median survival is still poor and usually does not reach 12 months. For a long time, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a2c81412d3fcc174ce7a0519461d8c
https://doi.org/10.1002/pro6.45
https://doi.org/10.1002/pro6.45
Autor:
Lovorka Batelja, Miroslav Samaržija, Željko Djaković, Suzana Kukulj, Bernard Budimir, Marko Jakopović, Kristina Krpina
Publikováno v:
Lung cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfa4b796344ae626ab7bc46681207e62
https://doi.org/10.1183/13993003.congress-2019.pa3060
https://doi.org/10.1183/13993003.congress-2019.pa3060
Autor:
Marko Jakopović, Kristina Krpina, Marta Korsic, Sonja Badovinac, Lela Bitar, Mihovil Roglić, Sanja Pleština, Ante Marušić, Fran Seiwerth, Miroslav Samarzija, Suzana Kukulj
Publikováno v:
Journal of Clinical Oncology. 38:e21110-e21110
e21110 Background: In extensive stage small-cell lung cancer (ES-SCLC) immune check-point inhibitors, atezolizumab and durvalumab, when combined with chemotherapy in the first-line setting show better efficacy than chemotherapy alone with safety prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90368eaa1bee5d2a7d5d97ce4b57e5ea
https://doi.org/10.1200/jco.2020.38.15_suppl.e21110
https://doi.org/10.1200/jco.2020.38.15_suppl.e21110
Autor:
J. Josip Grah, Miroslav Samaržija, Kristina Krpina, Marko Jakopović, Gordana Drpa, Lela Bitar, Fran Seiwerth, Blanka Cuk, Suzana Kukulj, Ante Marušić, Bernard Budimir
Publikováno v:
Lung Cancer.
Introducion: Lung carcinoid(LC)tumors account for 1–2% of all lung malignancies. They are classified as typical(TC)or atypical(AC)based on the mitotic index and/or the presence of necrosis. The utility of Ki-67 to differentiate between TCs and ACs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10ed8f14efb9647ff1a6acee9530543d
https://doi.org/10.1183/13993003.congress-2018.pa2782
https://doi.org/10.1183/13993003.congress-2018.pa2782